Study summary

The purpose of this study was to evaluate the efficacy of ASP0113 compared to placebo in reducing the incidence of cytomegalovirus (CMV) viremia in CMV-seronegative subjects receiving a kidney from a CMV-seropositive donor. This study also evaluated the safety of ASP0113 in this patient population.

Additional Study Details

Phase
2
Product
  • Placebo
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    150
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Scientific Results Summary 2
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English
    Protocol
    Available Language(s): English
    Statistical Analysis Plan (SAP)
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Withdrawn
      Site DE49004
      Frankfurt am M., Germany, 60596
      Withdrawn
      Site US10022
      Minneapolis, MN, United States, 55455
      Withdrawn
      Site FR33002
      Creteil, France, 94000
      Withdrawn
      Site FR33006
      Lyon, France, 69437
      Completed
      Site FR33004
      Nantes, France, 44000
      Completed
      Site ES34001
      Barcelona, Spain, 8907
      Withdrawn
      Site US10017
      Ft. Worth, TX, United States, 76104
      Withdrawn
      Site US10002
      Charlotte, NC, United States, 28203
      Completed
      Site US10042
      Pittsburgh, PA, United States, 15213
      Completed
      Site US10011
      Seattle, WA, United States, 98195-6175
      Completed
      Site US10018
      New Haven, CT, United States, 06520
      Withdrawn
      Site ES34007
      Palma de Mallorca, Illes Balears, Spain, 07120
      Completed
      Site US10041
      New Orleans, LA, United States, 70121
      Withdrawn
      Site US10052
      Louisville, KY, United States, 40202
      Completed
      Site US10038
      Charlottesville, VA, United States, 22903
      Withdrawn
      Site CA15001
      Montreal, QC, Canada, H3A 1A1
      Completed
      Site US10036
      San Francisco, CA, United States, 94115
      Completed
      Site DE49001
      Berlin, Germany, 13353
      Completed
      Site US10047
      Charleston, SC, United States, 29425
      Withdrawn
      Site DE49011
      Hannover, Germany, 30625
      Completed
      Site DE49003
      Erlangen, Germany, 91054
      Withdrawn
      Site US10005
      Livingston, NJ, United States, 07039
      Withdrawn
      Site US10054
      Spokane, WA, United States, 99204
      Withdrawn
      Site DE49007
      Tubingen, Germany, 72076
      Withdrawn
      Site US10021
      Chapel Hill, NC, United States, 27599-7211
      Completed
      Site US10031
      Richmond, VA, United States, 23298
      Withdrawn
      Site US10051
      Boston, MA, United States, 02115
      Withdrawn
      Site US10025
      San Antonio, TX, United States, 78229
      Completed
      Site DE49008
      Bonn, Germany, 53105
      Completed
      Site ES34003
      Barcelona, Barcelona, Spain, 08003
      Completed
      Site US10020
      Seattle, WA, United States, 98101
      Completed
      Site AU61001
      Adelaide SA, SA, Australia, 5000
      Completed
      Site US10028
      Houston, TX, United States, 77030
      Completed
      Site US10012
      Bronx, NY, United States, 10467
      Completed
      Site DE49002
      Berlin, Germany, 10117
      Completed
      Site ES34004
      Zaragoza, Spain, 50009
      Completed
      Site US10046
      Lexington, KY, United States, 40536
      Completed
      Site US10003
      Los Angeles, CA, United States, 90057
      Completed
      Site US10001
      Cleveland, OH, United States, 44106
      Withdrawn
      Site US10034
      New York, NY, United States, 10029
      Completed
      Site US10057
      Indianapolis, IN, United States, 46202
      Withdrawn
      Site US10024
      Cincinnati, OH, United States, 45219
      Withdrawn
      Site ES34006
      Cordoba, Spain, 14004
      Withdrawn
      Site US10007
      Durham, NC, United States, 27710
      Completed
      Site US10029
      Madison, WI, United States, 53792
      Withdrawn
      Site US10043
      New York, NY, United States, 10016
      Completed
      Site FR33001
      Nice, France, 66001
      Completed
      Site US10050
      Greenville, NC, United States, 27858
      Completed
      Site US10044
      Aurora, CO, United States, 80045
      Withdrawn
      Site US10032
      Columbus, OH, United States, 43210
      Completed
      Site CA15003
      Halifax, NS, Canada, B3H 1V8
      Completed
      Site FR33003
      Montpellier Cedex 5, France, 34295
      Withdrawn
      Site DE49009
      Dresden, Germany, 1307
      Completed
      Site FR33005
      Bordeaux, France, 33000
      Completed
      Site US10049
      Portland, ME, United States, 04102
      Completed
      Site CA15005
      London, ON, Canada, N6A 4V2
      Completed
      Site US10023
      Ann Arbor, MI, United States, 48109-5364
      Completed
      Site US10058
      Atlanta, GA, United States, 30309
      Completed
      Site US10037
      San Francisco, CA, United States, 94143
      Completed
      Site US10048
      Detroit, MI, United States, 48202
      Completed
      Site US10004
      San Diego, CA, United States, 92123
      Completed
      Site US10045
      Buffalo, NY, United States, 14215
      Completed
      Site US10030
      Chicago, IL, United States, 60612
      Completed
      Site US10027
      Nashville, TN, United States, 37232
      Completed
      Site US10013
      Atlanta, GA, United States, 30322
      Completed
      Site CA15006
      Toronto, ON, Canada, M5G2N2
      Completed
      Site AU61004
      Woolloongabba, QLD, Australia, QLD 4102
      Completed
      Site US10026
      Phoenix, AZ, United States, 85054
      Completed
      Site ES34002
      Barcelona, Barcelona, Spain, 08035
      Completed
      Site US10015
      Omaha, NE, United States, 68198
      Withdrawn
      Site DE49006
      Munster, Germany, 48149
      Completed
      Site US10009
      Chicago, IL, United States, 60637
      Completed
      Site US10014
      Salt Lake City, UT, United States, 84132
      Completed
      Site US10016
      St. Louis, MO, United States, 63110
      Completed
      Site CA15004
      Vancouver, BC, Canada, V6Z 1Y6
      Withdrawn
      Site US10056
      Houston, TX, United States, 77030
      Completed
      Site AU61002
      Sydney, NSW, Australia, NSW 2050
      Withdrawn
      Site US10006
      Dallas, TX, United States, 75246
      Withdrawn
      Site US10033
      San Antonio, TX, United States, 78229
      Completed
      Site DE49005
      Hamburg, Germany, 20246
      Withdrawn
      Site US10035
      New Orleans, LA, United States, 70112

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?